News | Digital Radiography (DR) | March 03, 2021

Carestream Showcases New Glass-Free Detector and Intelligent Solutions for Digital Radiography at Virtual ECR 2021

Carestream Health will highlight cutting-edge medical imaging technologies at the largest radiology meeting in Europe—the virtual European Congress of Radiology (ECR) in Vienna, Austria, beginning on March 3

March 3, 2021 — Carestream Health will highlight cutting-edge medical imaging technologies at the largest radiology meeting in Europe—the virtual European Congress of Radiology (ECR) in Vienna, Austria, beginning on March 3. The company will feature a wide range of products that demonstrates its leadership in digital medical imaging capture and processing, and improved user and workflow experiences.

“Our year is off to a great start with the launch of our first glass-free detector for medical imaging. The Carestream Lux 35 Detector is ergonomically designed to ease stress on radiographers and improve patient comfort,” said Michele Ferrarese, Europe Cluster Sales General Manager at Carestream. “Along with ImageView Software with Artificial Intelligence and Smart Features, our product portfolio significantly contributes to improved end-user workflow and image quality.”

Carestream’s medical imaging solutions highlighted at ECR 2021 include:

ImageView Software with Artificial Intelligence (AI) and Smart Features, included on the flexible, scalable CARESTREAM DRX-Compass X-ray System. Powered by the Eclipse engine, ImageView utilizes proprietary algorithms to increase the value of the entire imaging chain, from capture to diagnosis.

The Carestream Lux 35 Detector, a durable, lightweight glass-free detector for medical imaging. Weighing just under 2.13 kg without the battery, the sleek Lux 35 is Carestream’s lightest detector to date, making it simpler for technologists to transport and perform beside exams. Its ergonomic design enables easier handling and patient positioning.

Smart Noise Cancellation Software that uses AI with deep learning algorithms to remove (or cancel) noise and produce images that are significantly clearer than with standard processing. It provides improved anatomy clarity for images acquired at a broad range of exposures and enables customers to better optimize radiation dose. This software is pending FDA 510(k) clearance.

The DRX-Revolution Mobile X-ray System that provides fast, convenient digital radiography imaging for patients at the bedside and includes higher security features, noiseless navigation, functional LED lighting and in-bin detector charging.

The DRX-Revolution Nano Mobile X-ray System that utilizes Carbon Nano Tube (CNT) technology and provides high-quality digital radiography images for patients in tight spaces where size and maneuverability are critical. With a compact footprint and ultra-lightweight design, the portable, nonmotorized DRX-Revolution Nano is ideal for chest, intensive care, orthopaedic and pediatric imaging.

The Focus 35C and 43C Detectors which, together with Image Suite software, provide a retrofit solution that easily transforms an existing analog X-ray room into a digital one. Designed for smaller facilities, the cesium iodide (CsI) detectors increase productivity while supporting a higher standard of care; and 

The DRX-Transportable System/Lite that enables healthcare providers to affordably upgrade or transition existing room or mobile computed radiography (CR) systems to digital radiography (DR). This solution features a lightweight wireless tablet that allows for the capture and viewing of images at the point of patient care.

Carestream’s medical imaging portfolio can be seen 24/7 in our Virtual Hospital, an interactive platform where healthcare professionals can learn about the company’s medical imaging products and see them in an environment that closely mirrors a medical imaging facility.

“Carestream is committed to innovation,” Mr. Ferrarese added. “Our R&D team is focused on incorporating the voice of customer as we leverage AI technologies to provide enhanced, quantifiable benefits to patients and providers.”

For more information: www.carestream.com

Related Content

A doctor reading #CXR scans using #SenseCare-Chest #DR Pro #diagnostic #software.

A doctor reading CXR scans using SenseCare-Chest DR Pro diagnostic software.

News | Artificial Intelligence | April 14, 2021
April 14, 2021 — SenseTime, a world-leading...
Comparisons of high definition and standard definition infrared imaging for digital histopathology. Image courtesy of the Beckman Institute

Comparisons of high definition and standard definition infrared imaging for digital histopathology. Image courtesy of the Beckman Institute

News | Breast Imaging | April 14, 2021
April 14, 2021 — Detecting and analyzing breast cancer
The U.S. Food and Drug Administration (#FDA) authorized marketing of #Medtronic's #GIGenius, the first device that uses #artificialintelligence (#AI) based on #machinelearning to assist #clinicians in detecting #lesions (such as #polyps or suspected tumors) in the #colon in real time during a c#olonoscopy.

The GI Genius intelligent endoscopy module works in real-time, automatically identifying and marking (with a green box) abnormalities consistent with colorectal polyps, including small flat polyps.

News | Artificial Intelligence | April 12, 2021
A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Image used with permission of RSNA.

A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Read more about this case study. Image used with permission of RSNA.

Feature | Coronavirus (COVID-19) | April 09, 2021 | By Dave Fornell, Editor
While the mass COVID-19 vaccinat
3-D mammography reduces the number of breast cancer cases diagnosed in the period between routine screenings, when compared with traditional mammography, according to a large study from Lund University in Sweden. The results are published in the journal Radiology.

Getty Images

News | Breast Imaging | April 09, 2021
April 9, 2021 — 3-D mammography reduces the number of breast cancer cases diagnosed in the period between routine scr
IV contrast-enhanced 2-mSv 4-mm-thick transverse and coronal (b) CT images show inflamed diverticula (arrows), segmental colonic wall thickening, and adjacent pericolic fat stranding. Image courtesy of the American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

IV contrast-enhanced 2-mSv 4-mm-thick transverse and coronal (b) CT images show inflamed diverticula (arrows), segmental colonic wall thickening, and adjacent pericolic fat stranding. Image courtesy of the American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Computed Tomography (CT) | April 09, 2021
April 9, 2021 — According to an open-acc...
Futuristic campus design of Siemens Healthineers in Bengaluru, India.

Futuristic campus design of Siemens Healthineers in Bengaluru, India.

News | Radiology Business | April 08, 2021
April 8, 2021 — Siemens Healthineers announced t
Varian announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI) based diagnostic platform to aid in the fight against cancer. Varian and Google Cloud AI embarked on a deployment journey, using Neural Architecture Search (NAS) technology via Google Cloud AI Platform, to create AI models for organ segmentation — a crucial and labor-intensive step in radiation oncology that can be a bottleneck in the cancer treatment clinical workflow.
News | Artificial Intelligence | April 08, 2021
April 8, 2021 — Varian announced it is collaborating with Google...